On ECHEMI
Home > Drugs > Compound Baotaisong Millettia repens tablets

Compound Baotaisong Millettia repens tablets

Function and Efficacy

Not yet clear.

Ingredients

Phenylbutazone, vitamin C, vitamin B, Millettia spatholobi dry extract powder, etc.

Name Description Content CAS NO. Manufacturer
PhenylbutazoneIngredients

Not yet clear

More
50-33-9 10
Ascorbic AcidIngredients

Not yet clear

More
50-81-7 28

Appearance

This product is a sugar-coated tablet, which is brown after coating.

Indication

It is used for rheumatoid arthritis and persistent joint swelling and pain caused by rheumatoid arthritis. It is a national basic medicine for the treatment of rheumatic joint pain, a Chinese and Western compound preparation with rapid efficacy.

Usage and Dosage

Oral administration: 2 tablets at a time, 3 times a day.

Adverse Reactions

1. Phenylbutazone in this product has many adverse reactions and high toxicity. The incidence of side effects is about 10%~20%. 2. It is highly irritating to the gastrointestinal tract, which may cause nausea, vomiting, abdominal pain, constipation, etc. If used for too long or in excessive doses, it may cause digestive ulcers. 3. Phenylbutazone in this product may inhibit bone marrow function, causing granulocytopenia and even aplastic anemia. If discovered and discontinued in time, it can still be recovered, otherwise the prognosis is serious. 4. Phenylbutazone also causes sodium, chloride and water to be retained in the body, causing edema. It may also cause jaundice and hepatitis.

Precautions

1. It is contraindicated for patients with hypertension. 2. It is contraindicated for patients with edema or heart failure. 3. It is contraindicated for patients who are allergic to the ingredients of this product.

Special Population Medication

Precautions for children: Children should use with caution or follow the doctor's advice. Precautions for pregnancy and lactation: Pregnant and lactating women should use with caution or follow the doctor's advice. Precautions for the elderly: Elderly patients should use with caution or follow the doctor's advice.

Drug Interactions

1. This product contains phenylbutazone. If it is combined with dicoumarol, sulfonamides, and oral hypoglycemic drugs, it can increase the blood concentration of these drugs and easily cause toxicity. 2. This product can increase adverse reactions when used in combination with other non-steroidal anti-inflammatory drugs (such as aspirin). 3. This product can affect each other when used in combination with other drugs with high plasma protein binding rates, which can increase the concentration of free drugs in the blood.

Storage

seal.

Packaging Specification

Compound

Validity Period

24 months

Manufacturer

Rihui Pharmaceutical Co., Ltd.

  • Founded in:

    1998-12-15
  • Address:

    No. 358, Guangming North Road, Shengli Street, Huadian City, Jilin Province
  • Tax NO.:

    91220282702432588M
  • Registered Funds:

    91.351933 yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.